Лекарственноиндуцированные заболевания: эпидемиология и актуальность проблемы
- Авторы: Сычев Д.А1, Остроумова О.Д2, Кочетков А.И1, Переверзев А.П1, Остроумова Т.М1,2, Клепикова М.В1, Аляутдинова И.А1, Эбзеева Е.Ю1
-
Учреждения:
- Российская Медицинская академия непрерывного профессионального образования
- Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет)
- Выпуск: Том 27, № 5 (2020)
- Страницы: 77-84
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2073-4034/article/view/312641
- DOI: https://doi.org/10.18565/pharmateca.2020.5.77-84
- ID: 312641
Цитировать
Полный текст
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
Полный текст
Об авторах
Д. А Сычев
Российская Медицинская академия непрерывного профессионального образованияМосква, Россия
О. Д Остроумова
Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет)
Email: ostroumova.olga@mail.ru
д.м.н., зав. кафедрой терапии и полиморбидной патологии 125993, Россия, Москва, ул. Баррикадная, 2/1, стр. 1
А. И Кочетков
Российская Медицинская академия непрерывного профессионального образованияМосква, Россия
А. П Переверзев
Российская Медицинская академия непрерывного профессионального образованияМосква, Россия
Т. М Остроумова
Российская Медицинская академия непрерывного профессионального образования; Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет)Москва, Россия
М. В Клепикова
Российская Медицинская академия непрерывного профессионального образованияМосква, Россия
И. А Аляутдинова
Российская Медицинская академия непрерывного профессионального образованияМосква, Россия
Е. Ю Эбзеева
Российская Медицинская академия непрерывного профессионального образованияМосква, Россия
Список литературы
- Kantor E., Rehm C., Haas J.S., et al. Trends in prescription drug use among adults in the United States from 1999-2012. JAMA. 2015;314(17):1818-31. doi: 10.1001/jama.2015.13766.
- Tisdale J.E., Miller D.A. Drug Induced Diseases: Prevention, Detection, and Management. 3rd Ed. Bethesda, Md.: American Society of Health-System Pharmacists; 2018. 1399 р.
- Hales C.M., Servais J., Martin C.B., Kohen D. Prescription Drug Use Among Adults Aged 40-79 in the United States and Canada. NCHS Data Brief. 2019;(347):1-8.
- Сычев Д.А. (ред.). Полипрагмазия в клинической практике: проблема и решения. Учебное пособие. 2-е изд., испр. и доп. СПб., 2018. 272 с, ил.
- Kaplowitz N., DeLeve L.D. Drug-Induced Liver Disease. Third edition. Elsevier Sci. 2013. 1693 р.
- Factor S.A., Lang A.E., Weiner W.J. (ed.). Drug Induced Movement Disorders. Second edition. Wiley-Blackwell, 2008. 480 p.
- Drug-Induced Dementia: A Perfect Crime. Jackson G.E. Authorhouse. USA; 2009. 464 р.
- Begaud B. Dictionary of pharmacoepidemiology. Chichester, England: John Wiley and Sons; 2000. 182 p.
- Hallis J. Drug related hospital admissions in subspecialties of internal medicine. Dan. Med. Bull. 1996;43(2):141-55.
- Naranjo C.A., Busto U., Sellers E.M., et al. A metod for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-45. doi: 10.1038/clpt.1981.154.
- Institute for the Safety of Medicine. Quarter Watch. 2015 annular report (June 29, 2016). https:// www.ismp.org/quaterwatch/pdfs/2015Q4.pdf (accessed 2018 Jan 29).
- Bouvy J.C., De Bruin M.L., Koopmanschap M.A. Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies. Drug Saf. 2015;38(5):437-53. Doi: 10.1007/ s40264-015-0281-0. doi: 10.1371/journal. pone.0073166.
- Hakkarainen K.M., Andersson Sundel K., Petzold M., Hagg S. Prevalence and perceived preventability of self-reported adverse drug events: a population-based survey of 7099 adults. PLoS One. 2013;8(9):e73166.
- Hakkarainen K.M., Gyllensten H., Jonsson A.K., et al. Prevalence, nature and potential preventability of adverse drug events: a population-based medical record study of 4970 adults. Br J Clin Pharmacol. 2014;78(1):170-83. doi: 10.1111/bcp.12314.
- Letrilliart L., Hanslik T., Biour M., et al. Postdischarge adverse drug reactions in primary care originating from hospital care in France: a nationwide prospective study. Drug Saf. 2001;24(10):781-92. doi: 10.2165/00002018-200124100-00006.
- Khalil H., Huang C. Adverse drug reactions in primary care: a scoping review BMC Health Serv Res. 2020;20(1):5. Doi: https://doi.org/10.1186/s12913-019-4651-7
- Jacobs T.Q., Ross A. Adverse effects profile of multidrug-resistant tuberculosis treatment in a south African outpatient clinic. S Afr Fam Pract. 2012;54(6):531-39. doi: 10.1080/20786204.2012.10874288.
- Wucherer D., Thyrian J.R., Eichler T., et al. Drug related problems in community-dwelling primary care patients screened positive for dementia. Int. Psychogeriatr. 2017;29(11):1857-68. doi: 10.1017/S1041610217001442.
- Gandhi T.K., Weingart S.N., Borus J., et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556-64. Doi: 10.1056/ NEJMsa020703.
- Gurwitz J.H., Field T.S., Judge J., et al. The incidence of adverse drug events in two large academic longterm care facilities. Am J Med. 2005;118(3):251-58. doi: 10.1016/j.amjmed.2004.09.018.
- Aagaard L., Strandell J., Melskens L., et al. Global patterns of adverse drug reactions over a decade. Drug Saf. 2012;35(12):1171-82. doi: 10.2165/11631940-000000000-00000.
- Kaushal R., Goldmann D.A., Keohane C.A., et al. Adverse drug events in pediatric outpatients. Ambul Pediatr. 2007;7(5):383-89. doi: 10.1016/j.ambp.2007.05.005.
- Kowski A.B., Weissinger F., Gaus V, et al. Specific adverse effects of antiepileptic drugs-a true-to-life monotherapy study Epilepsy Behav. 2016;54:150-7. doi: 10.1016/j.yebeh.2015.11.009.
- Milligan F. Diabetes medication incidents in the care home setting. Nurs Stand. 2012;26(29):38-43. doi: 10.7748/ns2012.03.26.29.38.c8999.
- Montserrat-Capella D., Suarez M., Ortiz L., et al. AMBEAS Group. Frequency of ambulatory care adverse events in Latin American countries: the AMBEAS/PAHO cohort study. Int J Qual Health Care. 2015;27(1):52-9. doi: 10.1093/intqhc/mzu100.
- Schildmeijer K.G., Unbeck M., Ekstedt M., et al. Adverse events in patients in home healthcare: a retrospective record review using trigger tool methodology. BMJ. Open. 2018;8(1):e019267. doi: 10.1136/bmjopen-2017-019267.
- Tsang C., Majeed A., Banarsee R., Gnani S., Aylin P Recording of adverse events in English general practice: analysis of data from electronic patient records. Inform. Primary Care. 2010;18(2):117-24. doi: 10.14236/jhi.v18i2.761.
- Tomlin A., Reith D., Dovey S., Tilyard M. Methods for retrospective detection of drug safety signals and adverse events in electronic general practice records. Drug Saf. 2012;35(9):733-43. doi: 10.2165/11631970-000000000-00000.
- Woods D.M., Thomas E.J., Holl J.L., Weiss K.B., Brennan T.A. Ambulatory care adverse events and preventable adverse events leading to a hospital admission. Quality Saf Health Care. 2007;16(2):127-31. doi: 10.1136/qshc.2006.021147.
- Tache' S.V, Sönnichsen A., Ashcroft D.M. Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother. 2011;45(7-8):977-89. doi: 10.1345/aph.1P627.
- Kongkaew C., Noyce F.I.R., Ashcroft D.M. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008;42(7):1017-25. doi: 10.1345/aph.1L037.
- Al Hamid A., Ghaleb M., Aljadhey H., Aslanpour Z. A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br J Clin Pharmacol. 2013;78(2):202-17. doi: 10.1111/bcp.12293.
- Angamo M.T., Chalmers L., Curtain C.M., Bereznicki L.R. Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors. Drug Saf. 2016;39(9):847-57. doi: 10.1007/s40264-016-0444-7.
- Lea M., Mowe M., Mathiesen L., et al. Prevalence and risk factors of drug-related hospitalizations in multimorbid patients admitted to an internal medicine ward. PLoS ONE. 2019;14(7):e0220071. Doi: https://doi.org/10.1371/journal.pone.0220071.
- Tandon V.R., Khajuria V., Mahajan V., et al. Drug-induced diseases (DIDs): An experience of a tertiary care teaching hospital from India. Indian J. Med. Res. 2015;142(1):33-9. doi: 10.4103/0971-5916.162093.
- Oscanoa T.J., Lizaraso F., Carvajal A. Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol. 2017;73(6):759-70. doi: 10.1007/s00228-017-2225-3.
- Leendertse A.J., Van Den Bemt P.M., Poolman J.B., et al. Preventable hospital admissions related to medication (HARM): Cost analysis of the HARM study. Value in Heaith. 2011;14(1):34-40. doi: 10.1016/j.jval.2010.10.024.
- Manasse H.R. Jr. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 1. Am J Hosp Pharm. 1989; 46(5):929-44.
- Juntti-Patinen L., Neuvonen P.J. Drug-related deaths in a university central hospital. Eur J Clin Pharmacol. 2002;58(7):479-82. doi: 10.1007/s00228-002-0501-2.
- WHO 2013. European Hospital Morbidity Database. Availableat: http://data.euro.who.int/hmdb/index.php. Accessed 3 Sept 2014.
- European Commission. Proposal for a regulation amending, as regards pharmacovigilance of medicinal products for human use. Regulation (EC) No 726/2004. Impact assessment. 2008. Available at: http://ec.europa.eu/health/files/pharmacos/ pharmpack_12_2008/pharmacovigilance-iavol1_en.pdf. Accessed 3 Apr 2020.
- Lazarou J., Pomeranz B.H., Corey P.N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-205.
- Meier F., Maas R., Sonst A., et al. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs. Pharmacoepidemiol. Drug Saf. 2015;24(2):176-86. doi: 10.1002/pds.3663.
- Johnson J.A., Bootman J.L. Drug-related morbidity and mortality. Arch Intern Med. 1995;155(18):1945-56.
- Ernst F.R., Grizzle A.J. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41(2):192-99. doi: 10.1016/s1086-5802(16)31229-3.
- Writing Group Members, Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M., et al.; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart disease and stroke statistics-2016 update: a report from the Am. Heart Associat. Circulat. 2016;133(4):e38-360. doi: 10.1161/CIR.0000000000000350.
- Samp J.C. Touchette D.R., Marinac J.S., Kuo G.M; American College of Clinical Pharmacy Practice-Based Research Network Collaborative. Economic evaluation of the impact of medication errors reported by U.S. clinical pharmacists. Pharmacother. 2014;34(4):350-57. doi: 10.1002/phar.1370.
- Encinosa W.E., Bae J. Will meaningful use electronic medical records reduce hospital costs? Am J Manag Care. 2913;19(10 Spec. No):eSP19-25.